Not Much Better Than a Buy Back | Press Release | 03/01/2021
ORLANDO, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Since our writers and editors are always in search of trend (not fad) stories and potentially market disruptive changes in society, we’re obviously fans of the pet supply, health and wellness space, which has exploded during this COVID year.
Apparently, the management of health and wellness company Better Choice Company (OTCQX: BTTR) is as well, having bet on themselves and the Company’s future vis-à-vis a bold buy back announcement of the Company’s shares.
The details are important. Let’s take a look at some points that stand out to us, but before we do, please make sure to read the full release for all the details. This is just an excerpt.
Client Updates Delivered Straight To Your Inbox
The Company’s Board of Directors has authorized repurchases of up to $2,000,000 in shares.
At today’s price that is a significant purchase or practically speaking, really presents a potentially enormous ‘new’ investor into the equity.
Purchase can be made in the open market, which is again worth noting.
But for all this what is remarkable to us is that it is the Company betting on its own future. The people who know this business best find it investable and are intent on putting their own revenue back into the deal.
To say that is an infrequent event in the market, and this strata of the market, is an understatement but completely understandable given reports like these below:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.
We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.
EMC has been paid $170,000 by Better Choice Company, Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. | Please read our full disclaimer
Emerging Markets Consulting, LLC
390 North Orange Avenue, Suite 2300
Orlando, FL, US, 32801